Marko Marjanović
Impact in
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
-
- DNA and Nucleic Acid Chemistry
Papers in
-
- Bioactive Compounds and Antitumor Agents 3
-
- Synthesis and biological activity 8
- Synthesis and Biological Evaluation 4
- Synthesis of heterocyclic compounds 4
- Click Chemistry and Applications 4
- Co-authors
- Marijeta KraljTravis H. StrackerKrešimir PavelićGrace Karminski‐ZamolaIvo PiantanidaPhilip A. KnobelGordána PavlovićIgnasi Roig
In The Last Decade
Marko Marjanović
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Organic Chemistry 513
- Molecular Biology 599
- Cell Biology 142
- Toxicology 29
- Oncology 182
Countries citing papers authored by Marko Marjanović
This map shows the geographic impact of Marko Marjanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Marjanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Marjanović more than expected).
Fields of papers citing papers by Marko Marjanović
This network shows the impact of papers produced by Marko Marjanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Marjanović. The network helps show where Marko Marjanović may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marko Marjanović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 4 | |
| 4 | 2018 | 26 | |
| 5 | 2016 | 76 | |
| 6 | 2015 | 84 | |
| 7 | 2013 | 117 | |
| 8 | 2013 | 81 | |
| 9 | 2011 | 26 | |
| 10 | 2010 | 26 | |
| 11 | 2010 | 101 | |
| 12 | 2010 | 4 | |
| 13 | 2009 | 32 | |
| 14 | 2009 | 10 | |
| 15 | 2008 | 43 | |
| 16 | 2008 | 37 | |
| 17 | 2007 | 4 | |
| 18 | 2006 | 16 | |
| 19 | 2006 | 51 | |
| 20 | 2006 | 56 |
About Marko Marjanović
Marko Marjanović is a scholar working on Toxicology, Organic Chemistry, Biochemistry, Molecular Biology and Oncology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthesis and biological activity (8 papers), DNA and Nucleic Acid Chemistry (6 papers), Synthesis and Biological Evaluation (4 papers), Synthesis of heterocyclic compounds (4 papers), Click Chemistry and Applications (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), DNA Repair Mechanisms (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Organic Chemistry (513 citations), Molecular Biology (599 citations), Cell Biology (142 citations), Toxicology (29 citations) and Oncology (182 citations). Marko Marjanović has collaborated with scholars based in Croatia, Spain and Germany. Frequent co-authors include Marijeta Kralj, Travis H. Stracker, Krešimir Pavelić, Grace Karminski‐Zamola, Ivo Piantanida, Philip A. Knobel, Gordána Pavlović, Ignasi Roig, Marijana Hranjec and Vincenzo Costanzo. Their work appears in journals such as European Journal of Medicinal Chemistry, Investigational New Drugs, Organic & Biomolecular Chemistry, Bioorganic & Medicinal Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.